Search Results 421-430 of 16253 for Chronic Lymphocytic Leukemia
... Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). Jacksonville, Fla. The purpose of this study is to assess the safety and tolerability ...
A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia. Rochester, Minn. The purpose of this study is to compare whether minimal ...
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia. Molecular Therapy. 2020; doi:10.1016/j ...
... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...
Cerhan. Sections. Overview · Faculty and Staff; Research Research. Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia ... long-term ...
Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes. Blood Cancer ...
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia. Cancer Med. 2023 Dec; 12(23): ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.